Open-Label, Single-Dose, Randomized, 5-Period, 5-Way Crossover Study To Evaluate The Dose Proportionality And The Effects Of Food On The Bioavailability Of Acurox Tablets In Healthy Volunteers
Phase of Trial: Phase I
Latest Information Update: 18 Jun 2012
At a glance
- Drugs Oxycodone (Primary)
- Indications Pain
- Focus Pharmacokinetics
- Sponsors Pfizer
- 18 Jun 2012 Results published in Clinical Therapeutics.
- 22 Feb 2012 Actual patient number added 35 according to ClinicalTrials.gov.
- 16 Feb 2012 New trial record